Mid-regional Proadrenomedullin Biomarker Predicts Coronavirus Disease 2019 Clinical Outcomes: A US-Based Cohort Study

por Atallah, Natalie J, Panossian, Vahe S, Atallah, Christine J, Schwabe, Andrej, Johannes, Sascha, Wiemer, Jan, Mansour, Michael K
Publicado 2022

Baseline procalcitonin as a predictor of bacterial infection and clinical outcomes in COVID-19: A case-control study

por Atallah, Natalie J., Warren, Hailey M., Roberts, Matthew B., Elshaboury, Ramy H., Bidell, Monique R., Gandhi, Ronak G., Adamsick, Meagan, Ibrahim, Maryam K., Sood, Rupali, Bou Zein Eddine, Savo, Cobler-Lichter, Matthew J., Alexander, Natalie J., Timmer, Kyle D., Atallah, Christine J., Viens, Adam L., Panossian, Vahe S., Scherer, Allison K., Proctor, Teddie, Smartt, Sherrie, Letourneau, Alyssa R., Paras, Molly L., Johannes, Sascha, Wiemer, Jan, Mansour, Michael K.
Publicado 2022